Sort
64,565 grants matching “drug discovery”
Genetic Control of Addiction by Host and Microbiome
$821,864George M Weinstock · Jackson Laboratory · U01 · FY2019 · DA
Named Entity Recognition and Relationship Extraction in Biomedicine
$821,852Zhiyong Lu · National Library Of Medicine · ZIA · FY2013 · LM
Activity-based regulome profiling for the discovery of covalent transcription factor inhibitors
$821,779Alexander Federation · Talus Bioscience, Inc. · R44 · FY2024 · TR
Activity-based regulome profiling for the discovery of covalent transcription factor inhibitors
$821,779Alexander Federation · Talus Bioscience, Inc. · R44 · FY2025 · TR
Identifying driver mutations and tumor dependencies by comparative oncogenomics.
$821,775Scott W Lowe · Cold Spring Harbor Laboratory · U01 · FY2009 · CA
NOVEL PARADIGMS FOR DRUG DISCOVERY: COMPUTATIONAL MULTITARGET SCREENING
$821,700Ram Samudrala · University Of Washington · DP1 · FY2012 · LM
NOVEL PARADIGMS FOR DRUG DISCOVERY: COMPUTATIONAL MULTITARGET SCREENING
$821,700Ram Samudrala · University Of Washington · DP1 · FY2011 · OD
Multiplexed high-content assay for toxicity profiling using live iPSC-derived cardiomyocyte lines with lineage-specific barcoding
$821,559Mary Ludlam · Cairn Biosciences, Inc. · R44 · FY2019 · TR
Personalized cancer models to discover and develop new therapeutic targets.
$821,431Christopher J Kemp · Fred Hutchinson Cancer Research Center · U01 · FY2019 · CA
Imaging epigenetic dysregulation in the Lewy body dementias with [11C]Martinostat
$821,147Stephen N. Gomperts · Massachusetts General Hospital · R01 · FY2023 · AG
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
$821,084John M Maris · Children'S Hosp Of Philadelphia · R35 · FY2023 · CA
Higher Order Structure Analysis of Protein Therapeutics by Covalent Labeling MS
$821,023Eric Graban · Reclaim Pharmaceutical Waste Management · R44 · FY2018 · GM
Proteogenomic translator for cancer biomarker discovery towards precision medicine
$821,000Pei Wang · Icahn School Of Medicine At Mount Sinai · U24 · FY2025 · CA
Expanding the use of Tetrahymena as a protein expression platform
$820,959Paul Colussi · Tetragenetics, Inc. · R44 · FY2015 · GM
Genetics of novelty seeking and propensity for drug abuse in outbred rats
$820,863Huda Akil · University Of Michigan At Ann Arbor · U01 · FY2023 · DA
The MetaCyc & BioCyc Pathway/Genome Databases (SRI Proposal ECU 14-630)
$820,824Peter D Karp · Sri International · R01 · FY2018 · GM
BIOREPOSITORY OF HUMAN INDUCED PLURIPOTENT STEM CELLSFORCARDIOVASCULAR DISEASES (BHIPSC-CVD) - TASK AREA B
$820,477Joseph Wu · Stanford University · N01 · FY2021 · HL
CWRU/UHICC Phase I Trials of Anticancer Agents
$820,294Scot C Remick · Case Western Reserve University · U01 · FY2006 · CA
A 600 MHz NMR console and cryoprobe for studies of macromolecules, drug discovery and cancer biomarkers
$820,200John D Gross · University Of California, San Francisco · S10 · FY2018 · OD
Targeting Biotin Metabolism in Mycobacterium Tuberculosis
$820,039Courtney C Aldrich · University Of Minnesota · R01 · FY2019 · AI
Discovery of natural product-based drugs from Costa Rica
$819,851Jon Clardy · Harvard Medical School · U01 · FY2008 · TW
Discovery of natural product-based drugs from Costa Rica
$819,851Jon Clardy · Harvard Medical School · U01 · FY2007 · TW
Developing small molecule therapeutics for Ebola hemorrhagic fever virus
$819,724Arnab Basu · Microbiotix, Inc · R01 · FY2011 · AI
Biochemical Mechanism of HIV DNA Integration
$819,601Alan N. Engelman · Dana-Farber Cancer Inst · R37 · FY2025 · AI
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates
$819,421Jon Clardy · Harvard Medical School · U19 · FY2017 · TW